- Nimodipine (Nimotop®)Drug
Intervention Desc: Calcium channel blocker (L-type calcium channels)
Randomized, placebo-controlled, double-blind clinical trial of 31 patients.
Patients were randomized to receive nimodipine (120 mg/day) or placebo for 28 days. Treatment was begun within 48 hours of ischemic stroke.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Mathew's scale score at 4 weeks.|